Skin & Soft Tissue Infections (SSTI) Skin & Soft Tissue Infections. Skin & Soft Tissue Infections (SSTI)

Similar documents
Ca-MRSA Update- Hand Infections. Washington Hand Society September 19, 2007

Sixth Plague of Egypt. Community MRSA. Epidemiology. Basic Features of Community MRSA. Populations with CA-MRSA

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust

Community Methicillin- Resistant Staphylococcus aureus. Sixth Plague of Egypt. Epidemiology

HEALTH SERVICES POLICY & PROCEDURE MANUAL

S aureus infections: outpatient treatment. Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

5/17/2012 DISCLOSURES OBJECTIVES CONTEMPORARY PEDIATRICS

Tropical infections caused by Staphylococcus aureus

MRSA Background. New Challenges From an Old Foe. MRSA Demographics. Comparison of Types of MRSA CA-MRSA HA-MRSA

Infectious Disease Update 2017

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Infections caused by Methicillin-Resistant Staphylococcus

Getting Smart about Skin Infections and MRSA

Overview Management of Skin and Soft Tissue Infections in the MRSA Era

Methicillin Resistant Staphylococcus Aureus (MRSA) The drug resistant `Superbug that won t die

MRSA. ( Staphylococcus aureus; S. aureus ) ( community-associated )

MRSA Outbreak in Firefighters

TACKLING THE MRSA EPIDEMIC

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance

A. Incision and drainage alone B. Incision and drainage plus oral anti-mrsa antimicrobial agent C. Oral anti-mrsa antimicrobial agent

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

4/28/11. Update: 2011 IDSA MRSA Treatment Guidelines. Necrotizing fasciitis Animal bites Other skin and soft tissue infections

Staph Cases. Case #1

Skin and Soft Tissue Infections Emerging Therapies and 5 things to know

Methicillin Resistant Staphylococcus aureus:

Optimizing Antibiotic Treatment of Skin and Soft Tissue Infections

Prevalence & Risk Factors For MRSA. For Vets

Evaluating the Role of MRSA Nasal Swabs

Skin & Soft Tissue Infections (SSTIs)

What s New in MRSA? An Update on Legislative Mandates and MRSA in the Obstetrics/ Gynecology Patient

Epidemiology of Community- Associated (CA) Methicillin-Resistant Staphylococcus aureus (MRSA) in the United States

CA-MRSA lesions: What works, what doesn t

Source: Portland State University Population Research Center (

Geoffrey Coombs 1, Graeme Nimmo 2, Julie Pearson 1, Samantha Cramer 1 and Keryn Christiansen 1

Risk factors? Insect bites? Hygiene? Household crowding Health literacy

Antibiotic Updates: Part I

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

In This Issue: Community-Associated MRSA Infection Surveillance in Washoe County Final Report For Health Care Providers

Mrsa abscess and cellulitis

COMMUNITY ASSOCIATED METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS A PRACTICAL GUIDE FOR PRIMARY CARE PRACTITIONERS

Community-Associated Methicillin-Resistant Staphylococcus aureus: Review of an Emerging Public Health Concern

Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare

Le infezioni di cute e tessuti molli

5/26/10. Abscess, cellulitis Recurrent skin and soft tissue infections Necrotizing fasciitis Animal bites Unusual skin and soft tissue infections

GUIDE TO INFECTION CONTROL IN THE HOSPITAL

Staphylococcus Aureus

Cellulitis and Abscess: ED Phase v 1.1

Annual U.S. ED Visits for Skin and Soft Tissue Infections,

CA-MRSA: How Should We Respond to Outbreaks?

COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): WHAT YOU SHOULD KNOW

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

M R S A. Methicillin-Resistant Staphylococcus aureus. The Facts

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

Randomized, Controlled Trial of Antibiotics in the Management of Community-Acquired Skin Abscesses in the Pediatric Patient

New Antibiotics for MRSA

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Community Associated MRSA Dr. Rachel Gorwitz, CDC A Webber Training Teleclass

New Antibiotics & New Insights into Old Antibiotics

Management of Skin and Soft-Tissue Infection

Methicillin-Resistant Staphylococcus aureus

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant

Infectious Disease Issues in the Intensive Care Unit

Central Nervous System Infections

Health Care Associated Infection (HAI): A Critical Appraisal of the Emerging Threat Proceedings of the HAI Summit

Rational management of community acquired infections

Doxycycline staph aureus

Principles of Antimicrobial Therapy

Changing epidemiology of methicillin-resistant Staphylococcus aureus colonization in paediatric intensive-care units

Since its discovery in the 1960s, methicillinresistant

Clostridium difficile

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler

A Prospective Investigation of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic

Case: Family D. Staphylococcus aureus. Outline. Staphylococcus aureus Timeline. Newborn Nursery Epidemic: 1950s

Appropriate Antimicrobial Therapy for Treatment of

Development of Drugs for Skin Infections

Guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England

IDSA GUIDELINES EXECUTIVE SUMMARY

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

UNDERSTANDING THE ANTIBIOGRAM

CA-MRSA a new problem in Indonesia?

New Antibiotics & New Insights into Old Antibiotics

Impact of Systemic Antibiotics on Staphylococcus aureus Colonization and Recurrent Skin Infection

2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY

SKIN AND SOFT TISSUE INFECTIONS OCTOBER 3-4, 2015

Antibiotic Stewardship

Responders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members)

A hypothetical case of nasal microbiome transplantation

MRSA What Are Our Treatment Options and How Do We Choose the Right One?

Antibiotic Duration for Common Infections

IDSA GUIDELINES EXECUTIVE SUMMARY

FM - Male, 38YO. MRSA nasal swab (+) Due to positive MRSA nasal swab test, patient will be continued on Vancomycin 1500mg IV q12 for MRSA treatment...

Copyright 2012 Diabetes In Control, Inc. For permission to reprint, please contact Heather Moran, Production Editor, at

Transcription:

Skin & Soft Tissue Infections (SSTI) Skin & Soft Tissue Infections 2007 Abscess Cellulitis Bradley W Frazee, MD, FACEP Dept of Emergency Medicine Alameda County Medical Center - Highland Hospital Associate Clinical Professor of Medicine UCSF Necrotizing soft tissue infections (NSTI) Skin & Soft Tissue Infections (SSTI) SSTIs diagnostic approach: first look for pus! Community acquired-mrsa (CA-MRSA) (Abscess) Necrotizing soft tissue infections (NSTI) (Cellulitis) Redness, warmth, tenderness fluctuance or positive bedside ultrasound + Abscess* *Surgical diseases Cellulitis or NSTI* SSTIs Utility of ED ultrasound Diagnosis: unsuspected pus Procedural assistance: localize pus pocket for I&D Deltoid abscess -longitudinal view Contralateral normal shoulder Deltoid abscess -transverse view 1

Ultrasound appearance of cellulitis Isoechoic abscess w/ posterior acoustic enhancement Forearm cellulitis Normal Case #1 the old spider bite 40 y/o woman c/o a spider bite on leg. Onset 3 d/a. Hx same 1 mo/a. Notes husband had similar bite No PMH or Meds No IDU Afebrile. Community-associated MRSA (CA-MRSA) skin and soft tissue infections?!!??! Spontaneous furuncle 2

The story of CA-MRSA Hospital-associated MRSA (HA-MRSA) present since 60 s Multiresistant, SCCmec I-III Pts presenting from community with HA-MRSA infections had risk factors (recent hospitalization, SNF, HD ) CA-MRSA mid 1990 s Community onset MRSA infection - no risk factors Children in U.S. (pneumonia deaths); Native Americans; Australia; France Explosion of skin & soft tissue infections CA-MRSA Distinct genotype SCCmec IV Panton-Valentine Leukocidin (PVL) Distinct phenotype Antibiotic susceptibility: TMP/SMX, clinda, doxy Pathogenicity Spreads within communities outbreaks of skin & soft tissue infections Native American communities Prison inmates Sports teams CA-MRSA Prospective ED study Oakland, CA 2003-2004 Urban, county population 137 adult ED pts w/ skin and soft tissue infections Cultures of infection site & nares (colonization) Risk factor analysis Antibiogram and genotyping CA-MRSA Oakland ED study N=137 Young (<60) 18% homeless 27% IDU Frazee et al. Annals Emerg Med. 2005 CA-MRSA Oakland ED study culture results CA-MRSA Oakland ED study antibiograms USA 300 Nares culture N=137 Negative 97 MRSA 28 (20%) MSSA 12 Infection Site Cultures N=119 Other 14 Negative 26 MSSA 18 MRSA 61 (51%) Antibiotic Oxacillin Erythromycin Levofloxacin Tetracycline Clindamycin MSSA (N=30) 57.7 96.6 96.6 93.3 MRSA (N=89) 0.0 3.6 56.8 85.7 92.0 TMP-SMX Vancomycin Inducible clindamycin resistance (+ D-test) 3

CA-MRSA ED study genotyping of MRSA isolates 99% possessed SCCmec IV allele (marker of CA-MRSA) 87% were a single clone, USA 300 Not reported in California prior to 2000 Linked to MRSA in California prisons, sports team outbreaks Now predominant clone across USA 94% PVL + Instrumental in spontaneous furunculosis (?) Associated w/ necrotizing CA-MRSA pneumonia Multicenter National Study of SSTIs EMERGEncy ID NET OHSU OV-UCLA Maricopa UNM Hennepin UMissouri Charity Grady Bellevue Temple Carolinas Prevalence of MRSA across US 422 ED Patients with SSTI (August, 2004) 7/13 (54%) 24/47 (51%) MSSA 17% 59% 26/42 (62%) 24/47 (51%) 11/28 (39%) 43/58(74%) 23/32 (72%) 46/69 (67%) 4/20 (20%) 32/58 (55%) 17/25 (68%) Overall rise in ED visits for SSTI attributable to CA-MRSA? There has been a dramatic rise in the occurrence of S. aureus infections in general and CA-MRSA in particular Epidemic CA-MRSA disease has been reported in most, but not all, U.S. cities and from some rural areas. ED visits for SSTI 90 80 70 60 50 40 30 20 10 0 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 Daum. NEJM 2007 NHMCS preliminary data CA-MRSA risk factors & epidemiology CA-MRSA: antimicrobial options Risk factor data inconsistent: prior CA-MRSA infection (or close contact) Risk groups Prison inmates Contact sport teams HIV-positive American Indian Fomites (dressings, surfaces) Trimethoprim / Sulfamethoxazole (po, IV?) Clindamycin (po or IV) Doxycycline (po) Vancomycin (IV) Linezolid (po or IV) Daptomycin (IV) Dalbavancin (IV q week; not yet available) Rifampin (po) Mupirocin (topical) STOP are antibiotics really necessary? 4

Skin & soft tissue infection treatment algorithm (in setting of prevalence community-acquired MRSA) [2/05 version] Abscess incision & drainage Cellulitis Impetigo Must cover GAS* Keflex +/- TMP/SMX * GAS = Group A strep. Uncomplicated abscess Surgical treatment Strongly consider no Abx If Abx, cover MRSA Doxy or TMP/SMX alone TMP/SMX + keflex or Clindamycin alone Complicated abscess (significant surrounding cellulitis) Infected wound, foot ulcer, etc Immunocompromised host Consider surgical treatment Cover CA-MRSA & GAS po IV Clinda + vanco or Zosyn** + vanco ** if Gram neg. pathogen suspected Abscess I & D options for anesthesia and sedation Local Ring Block Local - bupivicaine ring block Regional anaesthesia Nitro-nox Conscious sedation - fentanyl + midazolam Short acting deep sedation in ED Methohexitol (+ fentanyl) Propofol (+ fentanyl) General anesthesia in OR How do you manage this thing? 5

Abscess post I&D antibiotics CA-MRSA uncomplicated abscess: are antibiotics needed? Literature is scant and non-uniform Uncomplicated abscess 3 prospective randomized trials: all 3 found no benefit to antibiotics NO NO NO surrounding cellulitis often invoked Rutherford. Lancet 1970 Llera. Ann EM 1985 Rajendran. Antimicrob Agents Chemother 2007 Nankin. Ann EM 2007 Maybe Yes CA-MRSA decolonization Other types of CA-MRSA infections: pyomyositis History of multiple furuncles Multiple cases in single household Nasal mupirocin Chlorhexidine (Hibicleanse) washes - axilla and groin Rifampin + TMP/SMX Spontaneous abscess of large muscles (e.g. thigh) Risk factors: diabetes & AIDS Formerly rare in nontropical countries Reports increasing adults and children Panaraj. CID 2006 Ruiz. NEJM 2005 6

Other types of CA-MRSA infections: necrotizing fasciitis 14 adults, Harbor-UCLA 6 IDU 12 monomicrobial for CA-MRSA All USA 300, PVL+ 0% mortality 1 case report of CA-MRSA nec fasc in a 5 d/o infant Miller. NEJM 2005 Dehority. Pediatr Infect Dis J 2006 Other types of CA-MRSA infections: septic arthritis (SA) & osteomyelitis (OM) Texas Children s Hospital 2001-2003, 193 invasive community acquired S. aureus infections Overall: 117 (61%) were CA-MRSA OM: 54 / 82 (66%) SA: 9 / 19 (47%) Arnold. J Ped Ortho 2006 Kaplan. CID 2005 Referral children s hospital in Tennessee, 2000-2004, orthopedic service, osteoarticular infections OM (n=89) SA (n=36) Both (n=33) MRSA 23 (50%) 7 (19%) 17 (51%) Other 20 12 10 Unknown 46 17 6 Other types of CA-MRSA infections: necrotizing pneumonia First cases of CA-MRSA infection in US, mid 1990 s, were fatal pneumonia in children Rare overall, but numerous reports in children and adults In setting influenza-like illness Necrotizing = cavitation and hemoptysis Leukopenia and sepsis syndrome, mortality Empiric vanco or linezolid for severe CAP during flu season? Francis. Clin Infect Dis 2005 Frazee. Ann Int Med 2005 7